Phathom Pharmaceuticals (PHAT) Insider Trading & Ownership $11.66 -0.40 (-3.33%) As of 11:34 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Phathom Pharmaceuticals (NASDAQ:PHAT) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage23.00%Number OfInsiders Buying(Last 12 Months)3Amount OfInsider Buying(Last 12 Months)$126.72KNumber OfInsiders Selling(Last 12 Months)4Amount OfInsider Selling(Last 12 Months)$277.00K Get PHAT Insider Trade Alerts Want to know when executives and insiders are buying or selling Phathom Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PHAT Insider Buying and Selling by Quarter Phathom Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/5/2025Robert Charles BreedloveInsiderSell461$12.09$5,573.49 7/16/2025Robert Charles BreedloveInsiderSell1,692$8.36$14,145.12 5/21/2025James N TopperDirectorBuy3,780$3.86$14,590.80 5/6/2025Asit ParikhDirectorBuy5,000$2.60$13,000.00 4/7/2025Molly HendersonCFOSell3,678$4.55$16,734.90 1/21/2025Azmi NabulsiCOOSell7,886$6.59$51,968.74 1/21/2025Molly HendersonCFOSell6,583$6.59$43,381.97 1/21/2025Terrie CurranInsiderSell19,109$6.59$125,928.31 12/19/2024Azmi NabulsiCOOSell1,118$8.00$8,944.00 12/19/2024Molly HendersonCFOSell1,291$8.00$10,328.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 12/13/2024Frank KarbeDirectorBuy12,500$7.93$99,125.00 (Data available from 1/1/2013 forward) PHAT Insider Trading Activity - Frequently Asked Questions Who is on Phathom Pharmaceuticals' Insider Roster? The list of insiders at Phathom Pharmaceuticals includes Asit Parikh, Azmi Nabulsi, Frank Karbe, James N Topper, Molly Henderson, Pharmaceutical Co Ltd Takeda, Robert Charles Breedlove, and Terrie Curran. Learn more on insiders at PHAT. What percentage of Phathom Pharmaceuticals stock is owned by insiders? 23.00% of Phathom Pharmaceuticals stock is owned by insiders. Learn more on PHAT's insider holdings. Which Phathom Pharmaceuticals insiders have been buying company stock? The following insiders have purchased PHAT shares in the last 24 months: Asit Parikh ($40,540.00), Frank Karbe ($99,125.00), and James N Topper ($14,590.80). How much insider buying is happening at Phathom Pharmaceuticals? Insiders have purchased a total of 24,780 PHAT shares in the last 24 months for a total of $154,255.80 bought. Which Phathom Pharmaceuticals insiders have been selling company stock? The following insiders have sold PHAT shares in the last 24 months: Azmi Nabulsi ($188,672.46), Molly Henderson ($319,070.58), Pharmaceutical Co Ltd Takeda ($29,999,994.30), Robert Charles Breedlove ($19,718.61), and Terrie Curran ($676,139.48). How much insider selling is happening at Phathom Pharmaceuticals? Insiders have sold a total of 3,833,680 Phathom Pharmaceuticals shares in the last 24 months for a total of $31,203,595.43 sold. Phathom Pharmaceuticals Key ExecutivesMs. Terrie J. Curran (Age 55)President, CEO & Director Compensation: $1.22MMr. David A. Socks (Age 49)Co-Founder & Director Compensation: $54.17kDr. Azmi Nabulsi M.D. (Age 64)M.P.H., Co-Founder & COO Compensation: $888.9kMs. Molly Henderson CPA (Age 53)MBA, Chief Financial & Business Officer Compensation: $777.76k1 recent tradesDr. Aditya Kohli Ph.D. (Age 36)Co-Founder Compensation: $319.65kMr. Paul CocjaChief People OfficerMr. Tom HarrisChief Development Sciences OfficerDr. Eckhard Leifke M.D.Ph.D., Chief Medical OfficerMr. Martin J. GilliganChief Commercial Officer More Insider Trading Tools from MarketBeat Related Companies Zai Lab Insider Selling Crinetics Pharmaceuticals Insider Selling Kymera Therapeutics Insider Selling Ultragenyx Pharmaceutical Insider Selling NewAmsterdam Pharma Insider Selling Viking Therapeutics Insider Selling Xenon Pharmaceuticals Insider Selling AMNEAL PHARMACEUTICALS Insider Selling Scholar Rock Insider Selling Immunovant Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Sell These High-Quality Stocks: Why Investors Shouldn’tCoreWeave and Madrigal's Insider Trades Flash Bullish SignalsPalantir Insider Selling: Risk Signal or Normal Activity?Loop Industries Insiders Buy Stock, Signal Confidence in OutlookDueling Insider Moves: Heavy Buying Here, Big Selling There This page (NASDAQ:PHAT) was last updated on 9/12/2025 by MarketBeat.com Staff From Our PartnersStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAlert: Prepare for Trump's Dollar OverhaulPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredGENIUS Act: The Plot to Seize Your Cash?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Phathom Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Phathom Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PHAT Stock Alerts